Femasys OKd on Infertility Treatment

 The 510(k) Clearance from the United States Food and Drug Administration (FDA) allows for the U.S. commercialization of FemaSeed®, an intratubal artificial insemination option designed to augment the natural fertilization process -

- FemaSeed® is an innovative infertility treatment designed to deliver sperm directly to where conception occurs in a woman’s fallopian tube -

https://finance.yahoo.com/news/femasys-inc-receives-u-fda-212500126.html